search
Back to results

2 Weeks of Citrulline Supplementation on Arterial Function in Postmenopausal Women With Elevated Blood Pressure or Hypertension

Primary Purpose

Menopause, Hypertension

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
L-Citrulline
Placebo
Sponsored by
Texas Tech University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Menopause focused on measuring Endothelial function, Blood flow, Blood pressure, Functional sympatholysis

Eligibility Criteria

50 Years - 70 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria: Postmenopausal women (defined as the absence of menstruation for at least 1 year). Resting systolic blood pressure 120-150 mmHg. Between the ages of 50 - 70 years. Sedentary (< 120 minutes of exercise/week). Body mass index of 25 - 39.9 kg/m2. Fasting glucose < 126 mg/dL and HbA1c < 6.5%. Exclusion Criteria: Body mass index ≥ 40 or < 25 kg/m2. Systolic blood pressure > 150 mmHg. Taking more than two antihypertensive medications. Cardiovascular diseases, type I/II diabetes, musculoskeletal disorders, or cancer. Changes in hypertensive medication in the past three months. Began or changed hormone replacement therapy in the past 6 months. Current smoker. Heavy drinking (> 7 alcoholic drinks/week). Participants on beta-blockers or other vasodilatory supplements (nitrates). Incorporated in a weight loss program and/or aerobic or resistance training program.

Sites / Locations

  • Texas Tech UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

L-Citrulline

Placebo

Arm Description

L-Citrulline: 6 grams/day divided in 2 equal doses

Microcrystalline cellulose: 8 capsules/day divided into 2 equal doses

Outcomes

Primary Outcome Measures

Macrovascular endothelial function at rest
Endothelial function will be assessed via brachial artery flow-mediated vasodilation (ultrasonography) during reactive hyperemia at baseline and after 2 weeks of each supplementation.
Microvascular endothelial function at rest
Endothelial function will be assessed via peripheral arterial tonometry (endoPAT) during reactive hyperemia at baseline and after 2 weeks of each supplementation.
Microvascular endothelial function at rest
Endothelial function will be assessed using forearm muscle oxygen saturation (near-infrared spectroscopy) during reactive hyperemia before and after 2 weeks of each supplementation.
Brachial artery blood flow at rest and during rhythmic handgrip exercise with and without lower-body negative pressure
Blood flow will be measured via Doppler ultrasound before and after 2 weeks of each intervention.
Forearm muscle oxygenation at rest and during rhythmic handgrip exercise with and without lower-body negative pressure
Muscle oxygen saturation will be measured via near-infrared spectroscopy before and after 2 weeks of each intervention.

Secondary Outcome Measures

Beat-to-beat blood pressure at rest and during rhythmic handgrip exercise with and without lower-body negative pressure
Blood pressure will be measured via a finger cuff (finometer) before and after 2 weeks of each intervention.
Aortic hemodynamics at rest and during rhythmic handgrip exercise with and without lower body negative pressure
Aortic blood pressure and pressure waves will be assessed using radial applanation tonometry before and after 2 weeks of each intervention.
Stroke volume at rest and during rhythmic handgrip exercise with and without lower body negative pressure
Stroke volume will be assessed via impedance cardiography before and after 2 weeks of each intervention.
Heart rate at rest and during rhythmic handgrip exercise with and without lower body negative pressure
Heart rate will be assessed via impedance cardiography before and after 2 weeks of each intervention.
Systemic vascular resistance at rest and during rhythmic handgrip exercise with and without lower body negative pressure
Systemic vascular resistance will be assessed via impedance cardiography before and after 2 weeks of each intervention.
Central and peripheral arterial stiffness at rest
Carotid-femoral and femoral-dorsalis pedis pulse wave velocity will be measured using arterial applanation tonometry before and after 2 weeks of each intervention.
Forearm muscle strength
Maximal forearm muscle strength will be measured using a handgrip dynamometer before and after 2 weeks of each intervention.
L-arginine levels
Serum levels of l-arginine will be assessed before and after 2 weeks of each intervention.
Nitric oxide levels
Serum levels of nitric oxide will be assessed before and after 2 weeks of each intervention.
L-citrulline levels
Serum levels of l-citrulline will be assessed before and after 2 weeks of each intervention.
L-ornithine levels
Serum levels of l-ornithine will be assessed before and after 2 weeks of each intervention.

Full Information

First Posted
August 19, 2023
Last Updated
August 29, 2023
Sponsor
Texas Tech University
search

1. Study Identification

Unique Protocol Identification Number
NCT06025383
Brief Title
2 Weeks of Citrulline Supplementation on Arterial Function in Postmenopausal Women With Elevated Blood Pressure or Hypertension
Official Title
2 Weeks of L-Citrulline Supplementation Improves Arterial Function and Systolic Blood Pressure at Rest and During Exercise in Postmenopausal Women With Elevated Blood Pressure and Hypertension
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 20, 2023 (Actual)
Primary Completion Date
July 2024 (Anticipated)
Study Completion Date
July 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Texas Tech University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of this project is to elucidate the effect of L-Citrulline (L-CIT) supplementation on vascular function at rest and during rhythmic handgrip exercise and functional sympatholysis via lower-body negative pressure in postmenopausal women with elevated blood pressure and hypertension.
Detailed Description
Using a double-blind, randomized, placebo-controlled, and crossover design, overweight or obese postmenopausal women with elevated blood pressure (BP) or hypertension will receive CIT (6 grams/day) or placebo for 2 weeks, separated by a two-week washout period. There will be a total of 5 laboratory visits. The 1st visit will take approximately 1 hour. The 2nd - 5th visits will take about 2 hours and 15 minutes. Visit 1 will be a screening visit, visits 2 and 4 will be considered baseline visits, and visits 3 and 5 will be following the participants' two weeks of supplementation. Arterial stiffness (carotid-femoral and femoral-dorsalis pedis pulse wave velocity) and endothelial function will be assessed at rest. Additionally, brachial artery blood flow, forearm muscle oxygenation, cardiovascular hemodynamics (stroke volume, cardiac output, systemic vascular resistance), and BP will be assessed at rest, during 6 minutes of rhythmic handgrip exercise at 30% of a predetermined maximal voluntary contraction, and 2 minutes of superimposed lower body negative pressure to increase sympathetic activity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Menopause, Hypertension
Keywords
Endothelial function, Blood flow, Blood pressure, Functional sympatholysis

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Cross-Over Assignment Double (Participant, Investigator) randomized, double-blind, placebo-controlled, cross-over study design
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
19 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
L-Citrulline
Arm Type
Experimental
Arm Description
L-Citrulline: 6 grams/day divided in 2 equal doses
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Microcrystalline cellulose: 8 capsules/day divided into 2 equal doses
Intervention Type
Dietary Supplement
Intervention Name(s)
L-Citrulline
Intervention Description
2 weeks of L-Citrulline supplementation (6 grams/day)
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
2 weeks of microcrystalline cellulose supplementation (8 capsules/day)
Primary Outcome Measure Information:
Title
Macrovascular endothelial function at rest
Description
Endothelial function will be assessed via brachial artery flow-mediated vasodilation (ultrasonography) during reactive hyperemia at baseline and after 2 weeks of each supplementation.
Time Frame
2 weeks of each intervention
Title
Microvascular endothelial function at rest
Description
Endothelial function will be assessed via peripheral arterial tonometry (endoPAT) during reactive hyperemia at baseline and after 2 weeks of each supplementation.
Time Frame
2 weeks of each intervention
Title
Microvascular endothelial function at rest
Description
Endothelial function will be assessed using forearm muscle oxygen saturation (near-infrared spectroscopy) during reactive hyperemia before and after 2 weeks of each supplementation.
Time Frame
2 weeks of each intervention
Title
Brachial artery blood flow at rest and during rhythmic handgrip exercise with and without lower-body negative pressure
Description
Blood flow will be measured via Doppler ultrasound before and after 2 weeks of each intervention.
Time Frame
2 weeks of each intervention
Title
Forearm muscle oxygenation at rest and during rhythmic handgrip exercise with and without lower-body negative pressure
Description
Muscle oxygen saturation will be measured via near-infrared spectroscopy before and after 2 weeks of each intervention.
Time Frame
2 weeks of each intervention
Secondary Outcome Measure Information:
Title
Beat-to-beat blood pressure at rest and during rhythmic handgrip exercise with and without lower-body negative pressure
Description
Blood pressure will be measured via a finger cuff (finometer) before and after 2 weeks of each intervention.
Time Frame
2 weeks of each intervention
Title
Aortic hemodynamics at rest and during rhythmic handgrip exercise with and without lower body negative pressure
Description
Aortic blood pressure and pressure waves will be assessed using radial applanation tonometry before and after 2 weeks of each intervention.
Time Frame
2 weeks of each intervention
Title
Stroke volume at rest and during rhythmic handgrip exercise with and without lower body negative pressure
Description
Stroke volume will be assessed via impedance cardiography before and after 2 weeks of each intervention.
Time Frame
2 weeks of each intervention
Title
Heart rate at rest and during rhythmic handgrip exercise with and without lower body negative pressure
Description
Heart rate will be assessed via impedance cardiography before and after 2 weeks of each intervention.
Time Frame
2 weeks of each intervention
Title
Systemic vascular resistance at rest and during rhythmic handgrip exercise with and without lower body negative pressure
Description
Systemic vascular resistance will be assessed via impedance cardiography before and after 2 weeks of each intervention.
Time Frame
2 weeks of each intervention
Title
Central and peripheral arterial stiffness at rest
Description
Carotid-femoral and femoral-dorsalis pedis pulse wave velocity will be measured using arterial applanation tonometry before and after 2 weeks of each intervention.
Time Frame
2 weeks of each intervention
Title
Forearm muscle strength
Description
Maximal forearm muscle strength will be measured using a handgrip dynamometer before and after 2 weeks of each intervention.
Time Frame
2 weeks of each intervention
Title
L-arginine levels
Description
Serum levels of l-arginine will be assessed before and after 2 weeks of each intervention.
Time Frame
2 weeks of each intervention
Title
Nitric oxide levels
Description
Serum levels of nitric oxide will be assessed before and after 2 weeks of each intervention.
Time Frame
2 weeks of each intervention
Title
L-citrulline levels
Description
Serum levels of l-citrulline will be assessed before and after 2 weeks of each intervention.
Time Frame
2 weeks of each intervention
Title
L-ornithine levels
Description
Serum levels of l-ornithine will be assessed before and after 2 weeks of each intervention.
Time Frame
2 weeks of each intervention

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Postmenopausal women (defined as the absence of menstruation for at least 1 year). Resting systolic blood pressure 120-150 mmHg. Between the ages of 50 - 70 years. Sedentary (< 120 minutes of exercise/week). Body mass index of 25 - 39.9 kg/m2. Fasting glucose < 126 mg/dL and HbA1c < 6.5%. Exclusion Criteria: Body mass index ≥ 40 or < 25 kg/m2. Systolic blood pressure > 150 mmHg. Taking more than two antihypertensive medications. Cardiovascular diseases, type I/II diabetes, musculoskeletal disorders, or cancer. Changes in hypertensive medication in the past three months. Began or changed hormone replacement therapy in the past 6 months. Current smoker. Heavy drinking (> 7 alcoholic drinks/week). Participants on beta-blockers or other vasodilatory supplements (nitrates). Incorporated in a weight loss program and/or aerobic or resistance training program.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Arturo Figueroa
Phone
806-834-5587
Email
Arturo.Figueroa@ttu.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Arturo Figueroa
Organizational Affiliation
Texas Tech University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Texas Tech University
City
Lubbock
State/Province
Texas
ZIP/Postal Code
79409
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Donna Torres
Phone
806-834-6935
Email
Donna.Torres@ttu.edu

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34974502
Citation
Maharaj A, Fischer SM, Dillon KN, Kang Y, Martinez MA, Figueroa A. Acute Citrulline Blunts Aortic Systolic Pressure during Exercise and Sympathoactivation in Hypertensive Postmenopausal Women. Med Sci Sports Exerc. 2022 May 1;54(5):761-768. doi: 10.1249/MSS.0000000000002848. Epub 2022 Jan 3.
Results Reference
background
PubMed Identifier
36297080
Citation
Maharaj A, Fischer SM, Dillon KN, Kang Y, Martinez MA, Figueroa A. Effects of L-Citrulline Supplementation on Endothelial Function and Blood Pressure in Hypertensive Postmenopausal Women. Nutrients. 2022 Oct 20;14(20):4396. doi: 10.3390/nu14204396.
Results Reference
background
PubMed Identifier
36615732
Citation
Kang Y, Dillon KN, Martinez MA, Maharaj A, Fischer SM, Figueroa A. Combined L-Citrulline Supplementation and Slow Velocity Low-Intensity Resistance Training Improves Leg Endothelial Function, Lean Mass, and Strength in Hypertensive Postmenopausal Women. Nutrients. 2022 Dec 23;15(1):74. doi: 10.3390/nu15010074.
Results Reference
background
PubMed Identifier
37049398
Citation
Figueroa A, Maharaj A, Kang Y, Dillon KN, Martinez MA, Morita M, Nogimura D, Fischer SM. Combined Citrulline and Glutathione Supplementation Improves Endothelial Function and Blood Pressure Reactivity in Postmenopausal Women. Nutrients. 2023 Mar 23;15(7):1557. doi: 10.3390/nu15071557.
Results Reference
background
PubMed Identifier
27160957
Citation
Figueroa A, Alvarez-Alvarado S, Jaime SJ, Kalfon R. l-Citrulline supplementation attenuates blood pressure, wave reflection and arterial stiffness responses to metaboreflex and cold stress in overweight men. Br J Nutr. 2016 Jul;116(2):279-85. doi: 10.1017/S0007114516001811. Epub 2016 May 10.
Results Reference
background

Learn more about this trial

2 Weeks of Citrulline Supplementation on Arterial Function in Postmenopausal Women With Elevated Blood Pressure or Hypertension

We'll reach out to this number within 24 hrs